Brief: Kolon Life Science Wins 19 Bln Won Contracts To Provide Arthritic Drug Overseas
14/01/2019 05:32
Jan 14 (Reuters) - Kolon Life Science Inc 102940.KQ :
* SAYS WINS CONTRACTS WORTH 19 BILLION WON ($16.92 million)
FROM
MUNDIPHARMA MEDICAL CO TO PROVIDE ARTHRITIC DRUG OVERSEAS
* ACQUIRES LOCAL LICENCING TO CARRY OUT CONTRACTS
Source text for Eikon: https://bit.ly/2Cpbd6m
https://bit.ly/2Cpbd6m,, https://bit.ly/2SOea7A
Further company coverage: 102940.KQ
($1 = 1,123.0000 won)
((Reuters Messaging: joori.roh.thomsonreuters.com@reuters.net))
Recent news on KOLON LIFE SCIENCE
See all newsBrief: Kolon Corp 2017/2018 Financial Statements Are Subject To Change Depending On Audit Results
Brief: Kolon Life Science Wins 19 Bln Won Contracts To Provide Arthritic Drug Overseas
Brief: Kolon Life Science signs contract worth 172.69 bln won
Brief: Kolon Life Science says issuance of bonus shares
Brief: Kolon Life Science to invest 78.5 bln won to set up new plant